No Data
No Data
Express News | Form 144 | Teva Pharmaceutical Industries(TEVA.US) Officer Proposes to Sell 6.1 Million in Common Stocks
Teva Pharmaceutical Indus Analyst Ratings
BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $22
Express News | Teva : BofA Global Research Raises Price Objective to $22 From $20
Why Teva Pharmaceutical Industries Limited (TEVA) Skyrocketed On Wednesday
10-Q: Q1 2025 Earnings Report
EZ_money : gold is good